CDO1 and myelodysplastic syndrome: Notably, we found a marked increase in CDO1 protein expression in nearly all matched biopsies of patients who progressed from MDS to secondary AML, and those who relapsed after AML diagnosis (Fig. 2d–g and Extended Data Fig. 4m–p).